BSECompany Update31 Jul 2026 · 31 Jul 2026, 10:10 pm

Intimation under Regulation 30 of SEBI Listing Regulations

Neuland Laboratories Ltd · 524558

✦ AI SummaryExpansion

Neuland Laboratories Ltd has commenced commercial production at two additional capacities under its expansion plans at Unit 1 and Unit 3 in Telangana, India.

Analysis Scores

Earnings Impact6/10
Growth Catalyst8/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Neuland Laboratories Ltd - 524558 - Intimation Under Regulation 30 Of SEBI Listing Regulations

Attachments (1)

📄

2822d0c2-75ef-4930-8c93-cd8233de4fc2.pdf

pdf

Download →
View document text
July 31, 2026 BSE Limited The National Stock Exchange of India Ltd Phiroze Jeejeebhoy Towers, 25th Floor, Exchange Plaza, Dalal Street, Mumbai – 400 001 Bandra Kurla Complex Bandra (E), Mumbai – 400 001 Scrip Code: 524558 Scrip Code: NEULANDLAB; Series: EQ Dear Sir/Madam, Sub : Intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations") Ref : Our letters dated August 1, 2024 and January 21, 2025 In continuation of our letters dated August 1, 2024 and January 21, 2025 and pursuant to Regulation 30 of the SEBI Listing Regulations, we would like to inform you that the Company has commenced the commercial production of the additional capacities under the expansion plans at Unit 1 situated at Bonthapally Village, Gummadidala Mandal, Sangareddy District, Telangana, India – 502313 and Unit 3 situated at Survey No. 10, Plot No. 3-72, Gaddapotharam Village, Jinnaram Mandal, Sangareddy District, Telangana - 502 319, respectively. This is for your information and records. Thanking you Yours Sincerely, For Neuland Laboratories Limited Sarada Bhamidipati Company Secretary